DK2194133T3 - Amylaser, nukleinsyrer, som koder for dem, og fremgangsmåder til fremstilling og anvendelse deraf - Google Patents

Amylaser, nukleinsyrer, som koder for dem, og fremgangsmåder til fremstilling og anvendelse deraf Download PDF

Info

Publication number
DK2194133T3
DK2194133T3 DK09180956.6T DK09180956T DK2194133T3 DK 2194133 T3 DK2194133 T3 DK 2194133T3 DK 09180956 T DK09180956 T DK 09180956T DK 2194133 T3 DK2194133 T3 DK 2194133T3
Authority
DK
Denmark
Prior art keywords
polypeptide
nucleic acid
sequence
amylase
mutagenesis
Prior art date
Application number
DK09180956.6T
Other languages
English (en)
Inventor
Walter Callen
Toby Richardson
Gerhard Frey
Kevin Gray
Janne S Kerovuo
Matgorzata Slupska
Nelson Barton
Eileen O'donoghue
Carl Miller
Original Assignee
Basf Enzymes Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/385,305 external-priority patent/US7560126B2/en
Application filed by Basf Enzymes Llc filed Critical Basf Enzymes Llc
Priority claimed from EP04718513A external-priority patent/EP1727898A4/en
Application granted granted Critical
Publication of DK2194133T3 publication Critical patent/DK2194133T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A21—BAKING; EDIBLE DOUGHS
    • A21D—TREATMENT, e.g. PRESERVATION, OF FLOUR OR DOUGH, e.g. BY ADDITION OF MATERIALS; BAKING; BAKERY PRODUCTS; PRESERVATION THEREOF
    • A21D8/00—Methods for preparing or baking dough
    • A21D8/02—Methods for preparing dough; Treating dough prior to baking
    • A21D8/04—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes
    • A21D8/042—Methods for preparing dough; Treating dough prior to baking treating dough with microorganisms or enzymes with enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12C—BEER; PREPARATION OF BEER BY FERMENTATION; PREPARATION OF MALT FOR MAKING BEER; PREPARATION OF HOPS FOR MAKING BEER
    • C12C5/00—Other raw materials for the preparation of beer
    • C12C5/004—Enzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2414—Alpha-amylase (3.2.1.1.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • C12N9/2411—Amylases
    • C12N9/2428—Glucan 1,4-alpha-glucosidase (3.2.1.3), i.e. glucoamylase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/16—Preparation of compounds containing saccharide radicals produced by the action of an alpha-1, 6-glucosidase, e.g. amylose, debranched amylopectin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/20—Preparation of compounds containing saccharide radicals produced by the action of an exo-1,4 alpha-glucosidase, e.g. dextrose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cereal-Derived Products (AREA)
  • Alcoholic Beverages (AREA)
  • Detergent Compositions (AREA)
  • Fodder In General (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Paper (AREA)
  • Jellies, Jams, And Syrups (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
  • Paints Or Removers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Claims (15)

1. Isoleret eller rekombinant nukleinsyre, som koder for et polypeptid med alpha-amylase-aktivitet, omfattende (a) en nukleinsyresekvens, der har mindst 90%, eller mere, eller har 100% sekvensidentitet med SEQ ID NO: 418 over hele længden af genet; (b) en nukleinsyre, som koder for et polypeptid, der har mindst 90%, eller mere, eller har 100% sekvensidentitet med SEQ ID NO:419, eller et enzymatisk aktivt fragment deraf, hvor fragmentet har alpha-amylase-aktivitet, (c) nukleinsyren af (a) eller (b), som mangler en signalsekvens eller et kulhydratbindende modul; (d) nukleinsyren af (a), (b) eller (c), som yderligere omfatter en heterolog sekvens, (e) nukleinsyresekvensen af (d), hvor den heterologe sekvens omfatter en sekvens, som koder for en heterolog signalsekvens, et kulhydratbindende modul, katalytisk domæne (CD), eller en kombination deraf, eller hvor den heterologe signalsekvens, det kulhydratbindende modul eller den katalytiske domæne (CD) er afledt fra et amylase-enzym eller et ikke-amylase-enzym; eller (f) en nukleinsyre, der er komplementær til (a), (b), (c), (d) eller (e).
2. Ekspressionskassette, en vektor eller en kloningsvehikel, omfattende en nukleinsyre omfattende en sekvens ifølge krav 1, hvor ekspressionskassetten, vektoren eller kloningsvehiklen omfatter en viral vektor, en plasmid, en fag, en fagemid, en kosmid, en fosmid, en bakteriofag eller en kunstig kromosom.
3. Transformeret værtscelle, omfattende en nukleinsyre, omfattende en sekvens ifølge krav 1, eller en ekspressionskassette, en vektor eller en kloningsvehikel ifølge krav 2, hvor den transformerede værtscelle er en bakteriecelle, en svampecelle, en gærcelle, en insektcelle eller en plantecelle.
4. Transgen ikke-humant dyr eller transgen plante eller transgen såsæd omfattende en sekvens ifølge krav 1, eller en ekspressionskassette, en vektor eller en kloningsvehikel ifølge krav 2.
5. Isoleret eller rekombinant polypeptid, som har en alpha-amylase-aktivitet bestående af (i) en aminosyresekvens, der har mindst 90 %, eller mere, eller har 100% sekvensidentitet med SEQ ID NO:419, eller et enzymatisk aktivt fragment deraf; (ii) et polypeptid, som kodes af en nukleinsyre, der har en sekvens ifølge krav 1; (iii) et polypeptid, som har aminosyresekvensen af (i) eller (ii), og omfatter mindst én konservativ substitution af aminosyrerest, hvor den konservative substitution omfatter udskiftning af en alifatisk aminosyre med en anden alifatisk aminosyre; udskiftning af en serin med en thre-onin eller omvendt; udskiftning af en syrerest med en anden syrerest; udskiftning af en rest med en amidgruppe med en anden rest med en amidgruppe; udskiftning af en basisk rest med en anden basisk rest; eller udskiftning af en aromatisk rest med en anden aromatisk rest eller en kombination deraf, og den alifatiske rest omfatter Alanin, Valin, Leucin, Isoleucin eller en syntetisk ækvivalent deraf; syreresten omfatter asparaginsyre, glutaminsyre eller en syntetisk ækvivalent deraf; hvor resten, som omfatter en amidgruppe, omfatter Asparagin, Glutamin eller en syntetisk ækvivalent deraf; hvor den basiske rest omfatter Lysin, Arginin eller en syntetisk ækvivalent deraf; eller den syntetiske rest omfatter Phenylalanin, Tyrosin en syntetisk ækvivalent deraf; (iv) polypeptidet af (i), (ii) eller (iii), som har en amylase, men mangler en signalsekvens eller et kulhydratbindende modul; (v) polypeptidet af (i), (ii), (iii) eller (iv) med en amylase-aktivitet og yderligere omfattende en eller flere heterologe sekvenser; (vi) polypeptidet af (v), hvor den ene eller flere heterologe sekvenser omfatter en heterolog signalsekvens, et kulhydratbindende modul, et katalytisk domæne (CD), eller en kombination deraf, eller den heterologe sekvens omfatter en heterolog epitop, rensningstag eller etikette; eller (vii) polypeptidet af (i), (ii), (iii), (iv), (v) eller (vi), yderligere omfattende mindst én glykosyleringsplads, hvor polypeptidet glykosyleres efter at være ekspri-meret i P. pastoris eller S. pombe, og polypeptidet bevarer en amylase-aktivitet under betingelser omfattende ca. pH 6,5, pH 6,0, pH 5,5, 5,0, pH 4,5 eller 4,0, og polypeptidet bevarer en amylase-aktivitet under betingelser omfattende ca. pH 8,0, pH 8,5, pH 9, pH 9,5, pH 10 eller pH 10,5.
6. Homodimer omfattende polypeptid ifølge krav 5 eller en heterodimer omfattende et polypeptid ifølge krav 5 og et andet domæne, hvor det andet domæne er et polypeptid, og heterodimeren er et fusionsprotein eller en epitop eller tag.
7. Immobiliseret polypeptid, hvor polypeptidet omfatter en sekvens ifølge krav 5, hvor polypeptidet er immobiliseret en celle, et metal, en harpiks, en polymer, en ceramik, et glas, en mikroelektrode, en grafitpartikel, en lille kugle, en gel, en plade, et array eller et kapillærrør.
8. Isoleret eller rekombinant antistof, som specifikt binder til et polypeptid ifølge krav 5 eller et polypeptid, der kodes af en nukleinsyre ifølge krav 1; hvor antistoffet er et monoklonalt eller et polyklonalt antistof.
9. Fremgangsmåde til fremstilling af et rekombinant, omfattende de følgende trin: (a) tilvejebringelse af en nukleinsyre, der er operabelt forbundet med en promotor, hvor nukleinsyren omfatter en sekvens ifølge krav 1; og (b) ek-sprimering af nukleinsyren i trin (a) under betingelser, som tillader eksprime-ring af polypeptidet, hvorved der produceres et rekombinant polypeptid, hvor fremgangsmåden yderligere omfatter en værtscelle med nukleinsyren i trin (a), efterfulgt af eksprimering af nukleinsyren i trin (a), hvorved der produceres et rekombinant polypeptid i en transformeret celle.
10. Fremgangsmåde til generering af en variant af en nukleinsyre, som koder for et polypeptid med en amylase-aktivitet, som omfatter følgende trin: (a) tilvejebringelse af en skabelonnukleinsyre omfattende en sekvens ifølge krav 1; og (b) modificere, slette eller tilføje en eller flere nukleotider i skabelonsekvensen, eller en kombination deraf, for at generere en variant af skabelonnukle-insyren; hvor fremgangsmåden yderligere omfatter eksprimering af variantnukleinsy-ren eller at generere en variant af skabelonnukleinsyren, og modificeringerne, tilføjelserne og sletningerne indføres med en fremgangsmåde, som omfatter fejltilbøjelig PCR, shuffling, oligonukleotid-styret mutagenese, assembly PCR, sexuel PCR-mutagenes, in vivo mutagenese, kassette-mutagenese, rekursiv ensemble-mutagenese, exponential-ensemble-mutagenese, sted-specifik mutagenese, gen-gensamling, gene-site-saturation-mutagenese (GSSM), syntetisk ligation-gensamlilng (SLR), rekombination, rekursiv sekvensrekombination, phosphothioat-modificeret DNA-mutagenese, uracil-indeholdende skabelon-mutagenese, gapped-duplex-mutagenese, point-mismatch-repair-mutagenese, reparatur-deficient-værtsstamme-mutagenes, kemisk mutagenese, radiomutagenese, deletion-smutagenese, restriktions-selektions-mutagenese, restriktions-rensnings-mutagenese, kunstig gen-syntese, ensemble-mutagenese, fremstilling af ki-mærisk nukleinsyre-multimer og en kombination deraf; og fremgangsmåden gentages iterativt, indtil en amylase, som har en ændret eller forskellig aktivitet eller en ændret eller forskellig stabilitet end polypepti-det, der kodes af skabelonnukleinsyren, er fremstillet, og amylase-polypeptid-varianten er termotolerant og beholder noget aktivitet efter at være udsat for en forhøjet temperatur, eller amylase-polypeptid-varianten har forhøjet glyko-sylering i sammenligning med den amylase, som kodes af en skabelonnukle-insyre, eller amylase-polypeptid-varianten har en amylase-aktivitet under en høj temperatur; og fremgangsmåden gentages iterativt, indtil en sekvens, som koder for en amylase, der har en ændret kodonanvendelse end skabelonnukleinsyren, er fremstillet; og fremgangsmåden gentages iterativt, indtil et amylase-gen, som har højere eller lavere niveau af beskedeksprimering eller stabilitet end skabelonnukleinsyren, er fremstillet.
11. Fremgangsmåde til hydrolyse af en polysaccharid, oligosaccharid eller stivelse eller at fjerne eller gøre en polysaccharid, oligosaccharid eller stivelse fra en sammensætning flydende, omfattende de følgende trin: (a) tilvejebringe polypeptidet ifølge krav 5, eller et polypeptid, der kodes af nukleinsyren ifølge krav 1; (b) tilvejebringe en sammensætning omfattende polysaccharid, oligosaccha-rid eller stivelse; og (c) bringe polypeptidet af trin (a) i kontakt med sammensætningen af trin (b) under forhold, hvor polypeptidet hydrolyserer, fjerner eller gør polysacchari-den, oligosacchariden eller stivelsen flydende, eller under betingelser, hvor polypeptidet fjerner eller gør polysacchariden, oligosacchariden eller stivelsen flydende. hvor sammensætningen omfatter en a-1,4-glucosidisk binding eller en a-1,6-glucosidisk binding.
12. Sammensætning omfattende polypeptidet af krav 5, eller et polypeptid, der kodes af nukleinsyren ifølge krav 1, hvor sammensætningen er udvalgt fra gruppen bestående af: en drik, et foder eller et levnedsmiddel, et fodertilskud til et dyr, en spiselig enzymindgi-velsesmatrix, et tekstile, papir eller et papirprodukt, papirmasse, en detergentsammensætning, en sammensætning til forhindre udtørring af brød, en farmaceutisk sammensætning, et mundplejeprodukt, en forsinket frigivelseseller kontrolleret frigivelsessammensætning, en olieboringsfluid og en bioblegningsopløsning.
13. Detergentsammensætning ifølge krav 12, hvor polypeptidet formuleres i en ikke-vandig, flydende sammensætning, et støbt faststof, en granulær form, en partikelform, en komprimeret tablet, en gelform, en pasta eller en opslæmningsform.
14. Fremgangsmåde til anvendelse af polypeptidet ifølge krav 5, eller det polypeptid, der kodes af en nukleinsyre ifølge krav 1; hvor anvendelsen er udvalgt fra gruppen bestående af: (a) forbedring af flydeevnen af en produktionsfluid fra en underjordisk formation; (b) forhindre udtørring af et bagt produkt, hvor det bagte produkt er et brød eller brødprodukt; (c) understøtte vækføringen af boreslam; (d) bio-blegning af et papir eller papirmasse; (e) krympning af tekstiler; (f) afsværtning af papir eller fibre; (g) behandling af lignocellulosiske fibre; (h) fremstilling af en sirup med højt indhold af maltose eller glukose; og (i) fremstilling af et foder eller levnedsmiddel.
15. Fremgangsmåde til fremstilling af ethanol, omfattende de følgende trin: (a) tilvejebringe polypeptidet ifølge krav 5, eller et polypeptid, der kodes af nukleinsyren ifølge krav 1; (b) tilvejebringe en sammensætning omfattende polysaccharid, oligosaccha-rid eller stivelse; og (c) bringe polypeptidet af trin (a) i kontakt med sammensætningen af trin (b) under forhold, hvor polypeptidet hydrolyserer polysacchariden, oligosaccha-riden eller stivelsen; eller: en fremgangsmåde til anvendelse af en amylase i brygning eller fremstilling af alkohol, omfattende de følgende trin: (a) tilvejebringe et polypeptid omfattende polypeptidet af krav 5, eller et polypeptid, der kodes af nukleinsyren ifølge krav 1; (b) tilvejebringe en sammensætning, der anvendes til brygning eller produktion af alkohol, omfattende polysaccharid, oligosaccharid eller stivelse; (c) kombinere polypeptidet af trin (a) med sammensætningen af trin (b) under forhold, hvor polypeptidet kan hydrolysere polysacchariden, oligosacchariden eller stivelsen i sammensætningen, som anvendes til brygning eller produktion af alkohol.
DK09180956.6T 2003-03-06 2004-03-08 Amylaser, nukleinsyrer, som koder for dem, og fremgangsmåder til fremstilling og anvendelse deraf DK2194133T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/385,305 US7560126B2 (en) 2001-02-21 2003-03-06 Amylases, nucleic acids encoding them and methods for making and using them
US45901403P 2003-03-28 2003-03-28
EP04718513A EP1727898A4 (en) 2003-03-06 2004-03-08 AMYLASES, NUCLEIC ACIDS ENCODING THESE AMYLASES AND METHODS OF PRODUCTION AND USE OF AMYLASES

Publications (1)

Publication Number Publication Date
DK2194133T3 true DK2194133T3 (da) 2016-02-29

Family

ID=33302725

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09180956.6T DK2194133T3 (da) 2003-03-06 2004-03-08 Amylaser, nukleinsyrer, som koder for dem, og fremgangsmåder til fremstilling og anvendelse deraf

Country Status (8)

Country Link
EP (3) EP3508578A1 (da)
JP (3) JP6177580B2 (da)
CN (2) CN102618564B (da)
CA (1) CA2920416A1 (da)
DK (1) DK2194133T3 (da)
ES (1) ES2713024T3 (da)
PL (1) PL3023498T3 (da)
ZA (1) ZA200508046B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015128397A (ja) * 2014-01-08 2015-07-16 国立大学法人広島大学 亜リン酸デヒドロゲナーゼ遺伝子、および、当該遺伝子を用いた出芽酵母の選択的培養方法
CN106011107B (zh) * 2016-06-30 2019-09-10 安徽工程大学 一种耐碱性α-淀粉酶及其基因工程菌的构建方法和应用
US20210198643A1 (en) * 2018-05-29 2021-07-01 Basf Se Amylase enzymes
JPWO2020090734A1 (ja) * 2018-10-31 2021-09-16 天野エンザイム株式会社 マルトトリオース生成アミラーゼ
KR102070415B1 (ko) * 2019-03-06 2020-01-28 고려대학교산학협력단 신규한 알파-아가레이즈 및 이를 이용한 한천 유래 홀수 개의 올리고당 생산 방법
CN113322295A (zh) * 2020-10-20 2021-08-31 河北肽丰生物科技有限公司 一种富硒黑小麦芽低聚糖肽的制备方法及其制品
CN114606221B (zh) * 2022-05-12 2022-09-02 凯莱英医药集团（天津）股份有限公司 固定化酶、其制备方法及应用
CN116949016B (zh) * 2023-09-21 2023-12-12 中国农业科学院生物技术研究所 葡萄糖淀粉酶ga51及其突变体和应用

Family Cites Families (140)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2615810A (en) 1948-03-04 1952-10-28 Wallerstein Company Retarding the staling of bakery products
US3026205A (en) 1959-08-19 1962-03-20 Baxter Laboratories Inc Process of producing baked confections and the products resulting therefrom by alpha amylase
US4458066A (en) 1980-02-29 1984-07-03 University Patents, Inc. Process for preparing polynucleotides
US5021246A (en) 1984-03-30 1991-06-04 Anheuser-Busch, Incorporated Step mashing process for producing low alcohol beer
US5087571A (en) 1984-06-22 1992-02-11 President And Fellows Of Harvard College Method for providing a cell culture from a transgenic non-human mammal
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
JP2584613B2 (ja) 1985-03-30 1997-02-26 バリベ、マール 組換えｄｎａ技術によってｄｎａ、ｒｎａ、ペプタイド、ポリペプタイド、または蛋白質を取得するための方法
US4962028A (en) 1986-07-09 1990-10-09 Dna Plant Technology Corporation Plant promotors
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
US4987071A (en) 1986-12-03 1991-01-22 University Patents, Inc. RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods
US5015580A (en) 1987-07-29 1991-05-14 Agracetus Particle-mediated transformation of soybean plants and lines
US5573933A (en) 1987-04-14 1996-11-12 Luminis Pty, Ltd. Transgenic pigs
JP2660836B2 (ja) * 1987-07-08 1997-10-08 株式会社 林原生物化学研究所 マルトテトラオース生成アミラーゼ活性を有するポリペプチドとその用途
US4788066A (en) 1987-12-14 1988-11-29 Grain Processing Corporation Preparation of low alcohol beer
US5700637A (en) 1988-05-03 1997-12-23 Isis Innovation Limited Apparatus and method for analyzing polynucleotide sequences and method of generating oligonucleotide arrays
US6054270A (en) 1988-05-03 2000-04-25 Oxford Gene Technology Limited Analying polynucleotide sequences
US5217879A (en) 1989-01-12 1993-06-08 Washington University Infectious Sindbis virus vectors
BR9000379A (pt) 1989-01-31 1990-12-04 Union Carbide Chem Plastic Polissacarideo soluvel em agua,processo para producao de um polissacarideo soluvel em agua,composicao de latex e processo para producao de uma composicao de latex
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5800992A (en) 1989-06-07 1998-09-01 Fodor; Stephen P.A. Method of detecting nucleic acids
US5527681A (en) 1989-06-07 1996-06-18 Affymax Technologies N.V. Immobilized molecular synthesis of systematically substituted compounds
DK474589D0 (da) 1989-09-27 1989-09-27 Novo Nordisk As Fremgangsmaade til fremstilling af bageriprodukter
US5589583A (en) 1990-01-11 1996-12-31 Monsanto Company Plant promoter
AU7791991A (en) 1990-04-24 1991-11-11 Stratagene Methods for phenotype creation from multiple gene populations
US5326477A (en) 1990-05-07 1994-07-05 Bio-Sep, Inc. Process for digesting solid waste
WO1991019810A1 (en) 1990-06-15 1991-12-26 California Biotechnology Inc. Transgenic non-human mammal displaying the amyloid-forming pathology of alzheimer's disease
JP3234598B2 (ja) 1990-11-23 2001-12-04 プラント・ジエネテイツク・システムズ・エヌ・ベー 単子葉植物の形質転換方法
WO1992011272A1 (en) 1990-12-20 1992-07-09 Ixsys, Inc. Optimization of binding proteins
NL9100050A (nl) 1991-01-11 1992-08-03 Heineken Technische Beheer Bv Werkwijze voor het continu bereiden van wort.
US5405624A (en) 1991-02-14 1995-04-11 Bio-Technical Resources Process for producing a product with an intensified beer flavor
US6110700A (en) 1991-03-11 2000-08-29 The General Hospital Corporation PRAD1 cyclin and its cDNA
US5922854A (en) 1991-06-14 1999-07-13 Kumar; Ramesh Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids
CA2075135A1 (en) 1991-08-02 1993-02-03 David E. Ellis Particle-mediated transformation of gymnosperms
US5632957A (en) 1993-11-01 1997-05-27 Nanogen Molecular biological diagnostic systems including electrodes
JPH05236997A (ja) 1992-02-28 1993-09-17 Hitachi Ltd ポリヌクレオチド捕捉用チップ
CA2127807A1 (en) 1992-11-20 1994-06-09 John Maliyakal Transgenic cotton plants producing heterologous bioplastic
CZ287462B6 (en) 1992-12-31 2000-11-15 Metallgesellschaft Ag Process for preparing beer
WO1995008914A1 (en) 1993-09-30 1995-04-06 Agracetus, Inc. Transgenic cotton plants producing heterologous peroxidase
EP0648843A1 (en) * 1993-10-01 1995-04-19 Takara Shuzo Co. Ltd. DNA encoding a hyperthermostable alpha-amylase
US6045996A (en) 1993-10-26 2000-04-04 Affymetrix, Inc. Hybridization assays on oligonucleotide arrays
US5965452A (en) 1996-07-09 1999-10-12 Nanogen, Inc. Multiplexed active biologic array
US6468742B2 (en) 1993-11-01 2002-10-22 Nanogen, Inc. Methods for determination of single nucleic acid polymorphisms using bioelectronic microchip
DK131193D0 (da) 1993-11-23 1993-11-23 Novo Nordisk As
US5605793A (en) 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
US6117679A (en) 1994-02-17 2000-09-12 Maxygen, Inc. Methods for generating polynucleotides having desired characteristics by iterative selection and recombination
US5837458A (en) 1994-02-17 1998-11-17 Maxygen, Inc. Methods and compositions for cellular and metabolic engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering
US5834252A (en) 1995-04-18 1998-11-10 Glaxo Group Limited End-complementary polymerase reaction
US5639940A (en) 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
WO1995024494A1 (en) 1994-03-09 1995-09-14 Abbott Laboratories Humanized milk
CA2184688A1 (en) 1994-03-09 1995-09-14 Pedro Antonio Prieto Transgenic animals producing oligosaccharides and glycoconjugates
MX196038B (es) 1994-03-29 2000-04-14 Novo Nordisk As Amilasa de bacillus alcalino.
US5807522A (en) 1994-06-17 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods for fabricating microarrays of biological samples
US5750870A (en) 1994-06-17 1998-05-12 Agritope, Inc. Plant genetic transformation methods and transgenic plants
US5582681A (en) 1994-06-29 1996-12-10 Kimberly-Clark Corporation Production of soft paper products from old newspaper
US5959171A (en) 1994-08-17 1999-09-28 Pharming B.V. Method for the production of biologically active polypeptides in a mammal's
WO1996006927A1 (en) 1994-09-01 1996-03-07 Merck & Co., Inc. Transgenic animal expressing a familial form of human amyloid precursor protein
US5795737A (en) 1994-09-19 1998-08-18 The General Hospital Corporation High level expression of proteins
US6111166A (en) 1994-09-19 2000-08-29 Medarex, Incorporated Transgenic mice expressing human Fcα and β receptors
US5880327A (en) 1994-09-21 1999-03-09 American National Red Cross Transgenic mammals expressing human coagulation factor VIII
US5556752A (en) 1994-10-24 1996-09-17 Affymetrix, Inc. Surface-bound, unimolecular, double-stranded DNA
US6187992B1 (en) 1994-12-05 2001-02-13 Merck & Co., Inc. Transgenic mouse having a disrupted amyloid precursor protein gene
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5633440A (en) 1994-12-20 1997-05-27 Dna Plant Technology Corporation P119 promoters and their uses
US6093562A (en) 1996-02-05 2000-07-25 Novo Nordisk A/S Amylase variants
US5959098A (en) 1996-04-17 1999-09-28 Affymetrix, Inc. Substrate preparation process
US5610225A (en) 1995-05-03 1997-03-11 National Starch And Chemical Investment Holding Corporation Latex paints which are free of volatile coalescents and freeze-thaw additives
JPH10510433A (ja) 1995-06-06 1998-10-13 アイシス・ファーマシューティカルス・インコーポレーテッド 高いキラル純度のホスホロチオエート結合を有するオリゴヌクレオチド
US5736499A (en) * 1995-06-06 1998-04-07 Genencor International, Inc. Mutant A-amylase
US5856174A (en) 1995-06-29 1999-01-05 Affymetrix, Inc. Integrated nucleic acid diagnostic device
US5985662A (en) 1995-07-13 1999-11-16 Isis Pharmaceuticals Inc. Antisense inhibition of hepatitis B virus replication
US5958672A (en) 1995-07-18 1999-09-28 Diversa Corporation Protein activity screening of clones having DNA from uncultivated microorganisms
US6057103A (en) 1995-07-18 2000-05-02 Diversa Corporation Screening for novel bioactivities
WO1997004160A1 (en) 1995-07-19 1997-02-06 Novo Nordisk A/S Treatment of fabrics
WO1997016533A1 (en) 1995-10-31 1997-05-09 The Regents Of The University Of California Mammalian artificial chromosomes and methods of using same
US5965408A (en) 1996-07-09 1999-10-12 Diversa Corporation Method of DNA reassembly by interrupting synthesis
US5830696A (en) 1996-12-05 1998-11-03 Diversa Corporation Directed evolution of thermophilic enzymes
US5939250A (en) 1995-12-07 1999-08-17 Diversa Corporation Production of enzymes having desired activities by mutagenesis
US6361974B1 (en) 1995-12-07 2002-03-26 Diversa Corporation Exonuclease-mediated nucleic acid reassembly in directed evolution
US6022963A (en) 1995-12-15 2000-02-08 Affymetrix, Inc. Synthesis of oligonucleotide arrays using photocleavable protecting groups
US6013440A (en) 1996-03-11 2000-01-11 Affymetrix, Inc. Nucleic acid affinity columns
US6096548A (en) 1996-03-25 2000-08-01 Maxygen, Inc. Method for directing evolution of a virus
US6025155A (en) 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6197070B1 (en) 1996-05-15 2001-03-06 The Procter & Gamble Company Detergent compositions comprising alpha combination of α-amylases for malodor stripping
AU3568897A (en) 1996-06-07 1998-01-05 Eos Biotechnology, Inc. Immobilised linear oligonucleotide arrays
WO1998006892A1 (en) 1996-08-16 1998-02-19 International Paper Company Enzymatic freeness enhancement
US6326341B1 (en) 1996-09-11 2001-12-04 The Procter & Gamble Company Low foaming automatic dishwashing compositions
AU4550997A (en) 1996-10-11 1998-05-11 Novo Nordisk A/S Cellulose binding domains (cbds) for oral care products
US6069122A (en) 1997-06-16 2000-05-30 The Procter & Gamble Company Dishwashing detergent compositions containing organic diamines for improved grease cleaning, sudsing, low temperature stability and dissolution
US6326204B1 (en) 1997-01-17 2001-12-04 Maxygen, Inc. Evolution of whole cells and organisms by recursive sequence recombination
EP2261373A3 (en) 1997-01-17 2011-12-14 Codexis Mayflower Holdings, LLC Evolution of whole cells and organisms by recursive sequence recombination
DE19703364A1 (de) 1997-01-30 1998-08-06 Henkel Ecolab Gmbh & Co Ohg Pastenförmiges Wasch- und Reinigungsmittel
WO1998040413A1 (en) 1997-03-14 1998-09-17 National Starch And Chemical Investment Holding Corporation Isolation of hemicellulose from corn fiber
JP4263248B2 (ja) 1997-03-18 2009-05-13 ノボザイムス アクティーゼルスカブ Ｄｎａのシャッフリングによるライブラリーの作成方法
IL131966A0 (en) 1997-03-18 2001-03-19 Novo Industri As An in vitro method for construction of a dna library
US5948653A (en) 1997-03-21 1999-09-07 Pati; Sushma Sequence alterations using homologous recombination
US6153410A (en) 1997-03-25 2000-11-28 California Institute Of Technology Recombination of polynucleotide sequences using random or defined primers
US6826296B2 (en) 1997-07-25 2004-11-30 Affymetrix, Inc. Method and system for providing a probe array chip design database
AU8908198A (en) 1997-08-15 1999-03-08 Hyseq, Inc. Methods and compositions for detection or quantification of nucleic acid species
PT1012564E (pt) 1997-09-11 2003-08-29 Bioventures Inc Metodo de producao de arranjos de alta densidade
US6465178B2 (en) 1997-09-30 2002-10-15 Surmodics, Inc. Target molecule attachment to surfaces
AU1124499A (en) 1997-10-28 1999-05-17 Maxygen, Inc. Human papillomavirus vectors
CA2845178A1 (en) 1997-10-30 1999-05-14 Novozymes A/S .alpha.-amylase mutants
AU1449499A (en) 1997-10-31 1999-05-24 Maxygen, Incorporated Modification of virus tropism and host range by viral genome shuffling
CA2309252C (en) 1997-11-10 2003-12-30 The Procter & Gamble Company Process for preparing a detergent tablet
CA2251263A1 (en) 1997-11-14 1999-05-14 Hajime Karasuyama Transgenic animal allergy models and methods for their use
WO1999028448A1 (en) * 1997-11-26 1999-06-10 Novo Nordisk A/S Thermostable glucoamylase
KR20010032861A (ko) 1997-12-08 2001-04-25 캘리포니아 인스티튜트 오브 테크놀로지 폴리뉴클레오티드 및 폴리펩티드 서열을 형성하는 방법
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
MXPA00007889A (es) 1998-02-11 2002-09-18 Maxygen Inc Optimizacion de las propiedades inmunomoduladoras de las vacunas geneticas.
JP2002507393A (ja) 1998-02-11 2002-03-12 マキシジェン， インコーポレイテッド 抗原ライブラリー免疫
ATE340870T1 (de) 1998-04-03 2006-10-15 Compound Therapeutics Inc Adressierbare protein arrays
US6156952A (en) 1998-04-09 2000-12-05 Constituent Institution Of The University Of Maryland System HIV transgenic animals and uses therefor
KR20010043194A (ko) 1998-05-01 2001-05-25 피아 스타르 Ｎ­히드록시아세트아닐라이드와 같은 증강제
US6048695A (en) 1998-05-04 2000-04-11 Baylor College Of Medicine Chemically modified nucleic acids and methods for coupling nucleic acids to solid support
DE19824705A1 (de) 1998-06-03 1999-12-09 Henkel Kgaa Amylase und Protease enthaltende Wasch- und Reinigungsmittel
ATE547532T1 (de) 1998-06-29 2012-03-15 Bristol Myers Squibb Co Verfahren zur erzeugung von hochgradig diversen bibliotheken
JP4335995B2 (ja) 1998-07-22 2009-09-30 昭 神谷 環境保全型粒状洗浄用組成物
FR2782323B1 (fr) 1998-08-12 2002-01-11 Proteus Procede de production in vitro de sequences polynucleotidiques recombinees, banques de sequences et sequences ainsi obtenues
WO2000015899A1 (en) 1998-09-17 2000-03-23 Novozymes North America, Inc. Methods for deinking and decolorizing printed paper
US6277628B1 (en) 1998-10-02 2001-08-21 Incyte Genomics, Inc. Linear microarrays
US6277489B1 (en) 1998-12-04 2001-08-21 The Regents Of The University Of California Support for high performance affinity chromatography and other uses
US6368861B1 (en) 1999-01-19 2002-04-09 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6436675B1 (en) 1999-09-28 2002-08-20 Maxygen, Inc. Use of codon-varied oligonucleotide synthesis for synthetic shuffling
US6376246B1 (en) 1999-02-05 2002-04-23 Maxygen, Inc. Oligonucleotide mediated nucleic acid recombination
US6511824B1 (en) 1999-03-17 2003-01-28 Exelixis, Inc. Nucleic acids and polypeptides of invertebrate TWIK channels and methods of use
US6309871B1 (en) 1999-03-31 2001-10-30 Novozymes A/S Polypeptides having alkaline α-amylase activity
US6221653B1 (en) 1999-04-27 2001-04-24 Agilent Technologies, Inc. Method of performing array-based hybridization assays using thermal inkjet deposition of sample fluids
GB9915214D0 (en) 1999-06-29 1999-09-01 Bp Exploration Operating Microemulsions
US6653151B2 (en) 1999-07-30 2003-11-25 Large Scale Proteomics Corporation Dry deposition of materials for microarrays using matrix displacement
EP1106603A3 (en) 1999-12-06 2003-11-19 Fuji Photo Film Co., Ltd. DNA chip and reactive solid carrier
US6531644B1 (en) 2000-01-14 2003-03-11 Exelixis, Inc. Methods for identifying anti-cancer drug targets
US6515109B1 (en) 2000-10-12 2003-02-04 Exelixis, Inc. Human ECT2 polypeptide
US6309872B1 (en) 2000-11-01 2001-10-30 Novozymes Biotech, Inc Polypeptides having glucoamylase activity and nucleic acids encoding same
WO2002068597A2 (en) * 2001-02-21 2002-09-06 Diversa Corporation Enzymes having alpha amylase activity and methods of use thereof
US7560126B2 (en) * 2001-02-21 2009-07-14 Verenium Corporation Amylases, nucleic acids encoding them and methods for making and using them
US20030082595A1 (en) * 2001-08-03 2003-05-01 Bo Jiang Nucleic acids of aspergillus fumigatus encoding industrial enzymes and methods of use
WO2014205447A2 (en) 2013-06-21 2014-12-24 Bio-Rad Laboratories, Inc. Microfluidic system with fluid pickups

Also Published As

Publication number Publication date
ES2713024T3 (es) 2019-05-17
PL3023498T3 (pl) 2019-05-31
CN102618564A (zh) 2012-08-01
ZA200508046B (en) 2011-10-26
JP2013236628A (ja) 2013-11-28
EP2194133A3 (en) 2010-12-29
JP6396371B2 (ja) 2018-09-26
CN102618564B (zh) 2014-10-29
CA2920416A1 (en) 2004-10-28
EP3508578A1 (en) 2019-07-10
EP2194133B1 (en) 2015-12-02
EP2194133A2 (en) 2010-06-09
EP3023498B1 (en) 2018-11-28
JP6177580B2 (ja) 2017-08-09
CN104388449A (zh) 2015-03-04
JP2015164421A (ja) 2015-09-17
JP6208163B2 (ja) 2017-10-04
EP3023498A1 (en) 2016-05-25
JP2017006131A (ja) 2017-01-12

Similar Documents

Publication Publication Date Title
US10066222B2 (en) Amylases, nucleic acids encoding them and method of producing an oil
US20200085070A1 (en) Amylases, Nucleic Acids Encoding Them and Methods for Making and Using Them
US7560126B2 (en) Amylases, nucleic acids encoding them and methods for making and using them
US20190062715A1 (en) Amylases, Nucleic Acids Encoding Them and Methods for Making and Using Them
WO2003083054A2 (en) Amylases, nucleic acids encoding them and methods for making and using them
US20070056053A1 (en) Glucosidases, nucleic acids encoding them and methods for making and using them
DK2194133T3 (da) Amylaser, nukleinsyrer, som koder for dem, og fremgangsmåder til fremstilling og anvendelse deraf
AU2017203481B2 (en) Amylases, nucleic acids encoding them and methods for making and using them
AU2013201807C1 (en) Amylases, nucleic acids encoding them and methods for making and using them